Invention Grant
- Patent Title: Lipopolysaccharide-binding protein for use in a method of treating alzheimer's disease
-
Application No.: US16640039Application Date: 2017-10-04
-
Publication No.: US11357822B2Publication Date: 2022-06-14
- Inventor: Etheresia Pretorius , Douglas Bruce Kell
- Applicant: Stellenbosch University
- Applicant Address: ZA Stellenbosch
- Assignee: Stellenbosch University
- Current Assignee: Stellenbosch University
- Current Assignee Address: ZA Stellenbosch
- Agency: Fitch, Even, Tabin & Flannery LLP
- Priority: ZA2017/05548 20170816
- International Application: PCT/IB2017/056118 WO 20171004
- International Announcement: WO2019/034922 WO 20190221
- Main IPC: A61K38/17
- IPC: A61K38/17 ; A61P25/28
Abstract:
A method for treating a subject suffering from Alzheimer's disease is provided. The method includes administering to the subject a therapeutically effective amount of lipopolysaccharide-binding protein (LBP). A composition including a therapeutically effective amount of LBP is also provided.
Public/Granted literature
- US20210187068A1 Lipopolysaccharide-Binding Protein For Use In A Method Of Treating Alzheimer's Disease Public/Granted day:2021-06-24
Information query
IPC分类:
